Caldolor FDA Approval History
Caldolor is an intravenous formulation of ibuprofen indicated for the management of mild to moderate pain and management of moderate to severe pain as an adjunct to opioid analgesics, as well as the reduction of fever in adults.
Development Timeline for Caldolor
|Jun 12, 2009||Cumberland Pharmaceuticals Announces FDA Approval of Caldolor|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.